Newsbot

Neue World ID: der Nachweis der Menschlichkeit für das Zeitalter der KI dehnt sich auf die digitalen Plattformen aus, die Menschen und Unternehmen jeden Tag nutzen

SAN FRANCISCO--(BUSINESS WIRE)--Letzte Woche kündigte World die nächste Generation von World ID an, sein Protokoll für den Nachweis der Menschlichkeit zur Stärkung des Vertrauens im Internet. Die Bekanntgabe wurde während „Lift Off“, einem Live-Event in San Francisco gemacht. Da es KI einfacher denn je macht, überzeugende Inhalte, Identitäten und Interaktionen zu erstellen, ist das Vertrauen im Internet gesunken. World ID begegnet dieser Herausforderung, indem es Einzelpersonen ermöglicht, priv

Orchid Island (ORC) Q1 2026 Earnings Transcript

Image source: The Motley Fool.DATEFriday, April 24, 2026 at 10 a.m. ETCALL PARTICIPANTSChief Executive Officer — Robert CauleyController — Jerry SintesPortfolio Manager — Hunter HaasNeed a quote from a Motley Fool analyst? Email pr@fool.comTAKEAWAYSNet Income (Loss) Per Share -- Net loss of $0.11 per share, down from net income of $0.62 per share in Q4.Book Value Per Share -- $7.08 per share at March 31, compared to $7.54 at December 31.Total Return -- Negative 1.3% versus a positive 7.8% i...

Equifax exposes AI fraud threat hitting modern business

A scammer can imitate your voice, forge your invoices, and create new identities in seconds, leaving the old fraud playbook mostly useless for modern businesses. Equifax warns that artificial intelligence is rewriting the rules of financial crime, and criminals have crossed a threshold many ...

How Expanding GLP?1 Offerings and Partnering With LillyDirect At Hims & Hers Health (HIMS) Has Changed Its Investment Story

In recent days, Hims & Hers Health expanded its platform so clinicians can prescribe Eli Lilly GLP?1 weight loss treatments, such as Zepbound vials, KwikPen, and Foundayo, with fulfillment routed through LillyDirect, while also broadening access to Novo Nordisk therapies and strengthening peptide capabilities via a facility acquisition ahead of an FDA review on compounding. This move deepens the company’s role in prescription weight management, potentially reshaping its product mix and...

Bank of America spotlights 401(k) tips you overlook

Your 401(k) is quietly doing one of two things for you: building the retirement you want or falling short of it. Most workers sign up for their employers retirement plan during onboarding, pick a contribution rate, and never think about it again. Bank of Americas Better Money Habits team ...

US, EU Reach Critical Minerals Deal to Weaken China’s Grip

The US and European Union on Friday reached an agreement to coordinate on securing critical minerals and bolstering supply chains, in a move meant to reduce reliance on China for rare earths and permanent magnets.

Eli Lillys new GLP-1 pill vs. Wegovy, JPMorgan initiates coverage on Hims

Market Catalysts Host Julie Hyman and Yahoo Finance Senior Reporter Brooke DiPalma track several of the days top trending stock tickers, including prescriptions for Eli Lillys (LLY) new GLP-1 weight-loss drug reportedly trailing the oral version of Novo Nordisks Wegovy (NVO), JPMorgan analysts initiating coverage on Hims & Hers Health stock (HIMS), and Regeneron (REGN) offering new hearing-loss therapy plans for free.

Börsenwoche: Warum US-Aktien so gut laufen

Die Inflationsgefahr steigt, der Irankrieg dauert an – und der US-Leitindex S&P 500 erreicht einen Höchststand. Ist das fundamental gerechtfertigt, oder blenden Anleger Risiken aus?

Bank of America has a blunt message for investors on IBM stock

IBM just posted one of its stronger quarters in years. Revenue beat. EPS beat. Margins expanded. And the stock still dropped more than 6% the morning after earnings. That reaction tells you something important about where IBM sits right now. And Bank of Americas response to the quarter is the ...

Commercial National Financial Corporation Reports 1st Quarter 2026 Results

ITHACA, Mich., April 24, 2026 (GLOBE NEWSWIRE) -- Commercial National Financial Corporation (OTCID: CEFC) reported net income of $1,677,000 or $0.43 per share for the first quarter of 2026 compared to $1,429,000 or $0.36 per share for the first quarter of 2025. Return on Equity was 11.87% for the first quarter of 2026 compared to 11.31% for the first quarter of 2025.

Fidelity sends blunt message on S&P 500 after sudden rebound

The S&P 500 has been on the comeback trail, but in a LinkedIn post, Fidelity strategist Jurrien Timmer isn’t ready to call the all-clear just yet. Following a remarkable rebound from recent lows, Timmer feels the rally has moved too far, too quickly. That calls for investors to separate a ...